Evidence map›Paper›PMID 33722512›Full record

ArticleJournal of immunological methods2021

Development of a non-biased, high-throughput ELISA for the rapid evaluation of immunogenicity and cross-reactivity.

Jamie E Fegan, Rong-Hua Yu, Epshita A Islam, Anthony B Schryvers

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunological methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evaluation of anNarra J · 2025
    Article
  5. Article
  6. Article
  7. Liquid Liver Biopsy for Disease Diagnosis and Prognosis.Journal of clinical and translational hepatology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jamie E FeganDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary T2N 4N1, Canada.
Rong-Hua YuDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary T2N 4N1, Canada.
Epshita A IslamDepartment of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto M5S 1A8, Canada.
Anthony B SchryversDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary T2N 4N1, Canada. Electronic address: schryver@ucalgary.ca.
University of Calgary · CAUniversity of Toronto · CA

Funding

Using gonococcal TonB-dependent transporters as vaccine antigensU19AI144182 · NIAID · GEORGIA STATE UNIVERSITY · PI CORNELISSEN, CYNTHIA N · 2019 to 2023
$9.3M
Gonococcal Vaccine Evaluation in a Humanized Mouse ModelR01AI103400 · NIAID · BOSTON MEDICAL CENTER · PI WETZLER, LEE MARK · 2013 to 2020
$5.2M
Production of a Gonococcal Vaccine for Countering Antimicrobial ResistanceR01AI141229 · NIAID · UNIVERSITY OF CALGARY · PI GRAY-OWEN, SCOTT D, MORAES, TREVOR F · 2019 to 2024
$4.4M
Rational design of transferrin binding protein-based vaccines to combat gonorrheaR01AI125421 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CORNELISSEN, CYNTHIA N, GRAY-OWEN, SCOTT D · 2017 to 2021
$3.1M
CIHR MOP-130273NIAID NIH HHS R01 AI103400NIAID NIH HHS R01 AI125421NIAID NIH HHS R01 AI141229NIAID NIH HHS U19 AI144182
6 · The paper itself

Abstract

Traditional ELISA-based protein analysis has been predicated on the assumption that proteins bind randomly to the solid surface of the ELISA plate polymer (polystyrene or polyvinyl chloride). Random adherence to the plate ensures equal access to all faces of the protein, an important consideration when evaluating immunogenicity of polyclonal serum samples as well as when examining the cross-reactivity of immune serum against different antigenic variants of a protein. In this study we demonstrate that the soluble form of the surface lipoprotein transferrin binding protein B (TbpB) from three different bacterial pathogens (Neisseria meningitidis, Actinobacillus pleuropneumoniae, and Mannheimia haemolytica) bind the ELISA plate in a manner that consistently obscures the transferrin binding face of the proteins' N-lobe. In order to develop a non-biased ELISA where all faces of the protein are accessible, the strong interaction between biotin and avidin has been exploited by adding a biotin tag to these proteins during Escherichia coli-based cytoplasmic expression and utilizing streptavidin or neutravidin coated ELISA plates for protein capture and display. The use of avidin coated ELISA plates also allows for rapid purification of biotin-tagged proteins from crude E. coli lysates, removing the requirement of prior affinity purification of each protein to be included in the ELISA-based analyses. In proof of concept experiments we demonstrate the utility of this approach for evaluating immunogenicity and cross-reactivity of serum from mice and pigs immunized with TbpBs from human and porcine pathogens.

Indexed as

Enzyme-Linked Immunosorbent AssayActinobacillus pleuropneumoniaeAvidinBiotinMannheimia haemolyticaNeisseria meningitidisPolystyrenesPolyvinyl ChlorideTransferrin-Binding Protein BAvidinBiotinPolystyrenesPolyvinyl ChlorideTransferrin-Binding Protein BAntibodyAntigenELISAImmunologyVaccine

Identifiers

PMID33722512
PMCPMC8107143
OpenAlexW3137621775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.